The Global Pediatric Drugs and Vaccines Market size is expected to grow at a CAGR of 6.8% during the forecast period, to reach $38.7 billion in 2028 from $16.2 billion in 2021, driven by factors such as an increasing number of children being diagnosed with chronic diseases and rise in preventive healthcare expenditure for children across various regions globally. The newborn segment dominates the global pediatric drugs and vaccines market owing to the higher incidence rate among this population group which can lead to lifelong health problems if not addressed timely or adequately.
Pediatric drugs and vaccines are medications designed to target the needs of children. Pediatric drugs and vaccines can be broken down into four categories: diphtheria, influenza, hepatitis, pneumococcal diseases (pneumonia), meningococcal diseases (meningitis) mumps, other infectious agents). These types help protect children from these infections that they are most likely going to come in contact with due to their age group.
On the basis of Types, the market is segmented into diphtheria, influenza, hepatitis, pneumococcal diseases (pneumonia), meningococcal diseases (meningitis) mumps.
Diphtheria is a bacterial disease that affects the upper respiratory tract in humans. It can lead to breathing problems, heart failure, and paralysis. Diphtheria is caused by "Corynebacterium diphtheria," which has a Gram-positive cell wall coated with polysaccharides (nonmotile). The bacteria are nonencapsulated bacilli on inoculation of mucous membrane surfaces. The incubation period lasts for two weeks or more before symptoms appear due to the toxin released from living bacteria cells into body tissues causing inflammation and damage. Healthy people who get infected usually recover within a week without treatment if their immune system responds appropriately against toxins.
Influenza is a contagious respiratory illness with symptoms that can last for up to two weeks. Influenza (flu) spreads easily and can cause mild to severe illnesses, even death. In young children, it may lead to complications such as pneumonia which could be fatal. The viruses responsible for flu are constantly changing - they're different from one season to the next and they also change within each passing season.
The term hepatitis refers to a group of viral diseases with similar symptoms. Hepatitis A, B, and C can all be transmitted through the stomach or food (hepatitis A) as well as by sexual contact (Hepatitis B and C). These viruses are found throughout the world but some are more prevalent than others in certain regions.
On the basis of Application, the market is segmented into Newborn, Infant,
Pediatric drugs and vaccines are used in newborns to prevent a variety of conditions, including diphtheria, influenza (flu), hepatitis, pneumococcal diseases, meningococcal infections. These products can also be prescribed for infants or children with these medical conditions.
The use of Pediatric Drugs and Vaccines in infants is expected to grow on account of the rising demand for vaccines, drugs that inhibit morbidity and mortality rates due to childhood diseases such as influenza type A (HIV), pertussis, diphtheria, tetanus disease, etc. Moreover, increasing public awareness about safety aspects related to vaccination programs may also drive this market.
The use of pediatric drugs and vaccines in children is to prevent diseases that are not included in the vaccination schedule. Among these, diphtheria vaccine, hepatitis A and B vaccine, pertussis (whooping cough) vaccine, poliovirus oral drops or injection – live attenuated vaccines with a combination of diphtheria-tetanus-pertussis (DTP), measles-mumps-rubella (MMR), varicella-zoster virus live-attenuated combined measles-mumps-rubella vaccine for healthy people 12 months old or older; influenza vaccines for all ages; pneumococcal polysaccharide 24 valent (PPSV24) conjugate bivalent 13 serotype strains vaccine for healthy people 65 years old or older.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America with the US as its major contributor is expected to dominate the global pediatric drugs and vaccines market in 2021-2028 followed by Europe due to the high prevalence of diseases among children resulted from low vaccination coverage rates.
The Asia Pacific is expected to be the fastest-growing region in terms of revenue, owing to the presence of a large number of pediatric patients.
Increasing incidences and prevalence rates of various diseases among children are expected to be one of the major factors driving growth for this market over the next few years. In addition, increasing public awareness about childhood vaccinations has resulted in a higher adoption rate for vaccine products and other preventive measures such as pre-exposure prophylaxis against Hepatitis B virus infections have also contributed towards improving quality standards across geographies due to which companies continue investing in research & developments activities with an aim on bringing newer vaccines or drug therapies that cater to the changing needs of children.
Up Market Research published a new report titled “Pediatric Drugs and Vaccines Market research report which is segmented by Types (Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Mumps, Others), By Applications (Newborn, Infant, Child), By Players/Companies Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Genentech, Inc. (USA), GlaxoSmithKline plc. (UK), Janssen Biologics B.V. (USA), Actelion Pharmaceuticals, AstraZeneca Plc. (UK), Boehringer Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (USA), Allergan, Inc. (USA), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Pfizer, Inc. (USA), Sanofi S.A (France), Shionogi Inc. (USA), Takeda”.
|Report Attributes||Report Details|
|Report Title||Pediatric Drugs and Vaccines Market Research Report|
|By Type||Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Mumps, Others|
|By Application||Newborn, Infant, Child|
|By Companies||Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Genentech, Inc. (USA), GlaxoSmithKline plc. (UK), Janssen Biologics B.V. (USA), Actelion Pharmaceuticals, AstraZeneca Plc. (UK), Boehringer Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (USA), Allergan, Inc. (USA), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Pfizer, Inc. (USA), Sanofi S.A (France), Shionogi Inc. (USA), Takeda|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||234|
|Number of Tables & Figures||164|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Mumps, Others and By Application Newborn, Infant, Child.
Some of the companies that are profiled in this report are:
Pediatric Drugs and Vaccines Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Pediatric Drugs and Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Pediatric Drugs and Vaccines Market Report:
Some other reports from this category!